Jeffrey B. Mirviss Form 3 Filing - Director Appointment with No Initial Holdings

This Form 3 filing reports that Jeffrey B. Mirviss became a Director of CONMED Corp on July 1, 2026. The filing indicates that as of his appointment date, Mr. Mirviss owns zero shares of CONMED common stock. The filing was signed by Thomas Fistek on behalf of Jeffrey B. Mirviss using a power of attorney on July 2, 2026. This is an initial statement of beneficial ownership required for new directors under Section 16 of the Securities Exchange Act of 1934. The filing shows that while Mr. Mirviss has been appointed to the board, he has not yet acquired any equity position in the company as of the reporting date.